These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19253181)

  • 1. [Usefulness of apraclonidine in the diagnosis of Horner syndrome].
    Pérez-Iñigo MA; González I; Fernández FJ; Díaz S; Ferrer C; Alias E; Honrubia FM
    Arch Soc Esp Oftalmol; 2009 Feb; 84(2):105-8. PubMed ID: 19253181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False negative apraclonidine test in two patients with Horner syndrome.
    Kawasaki A; Borruat FX
    Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diagnosis of Horner syndrome using topical apraclonidine.
    Cooper-Knock J; Pepper I; Hodgson T; Sharrack B
    J Neuroophthalmol; 2011 Sep; 31(3):214-6. PubMed ID: 21566530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.
    Bacal DA; Levy SR
    Arch Ophthalmol; 2004 Feb; 122(2):276-9. PubMed ID: 14769608
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 0.5% apraclonidine on ptosis in Horner syndrome.
    Garibaldi DC; Hindman HB; Grant MP; Iliff NT; Merbs SL
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):53-5. PubMed ID: 16418668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
    Chen PL; Hsiao CH; Chen JT; Lu DW; Chen WY
    Am J Ophthalmol; 2006 Sep; 142(3):469-74. PubMed ID: 16935593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients.
    Chen PL; Chen JT; Lu DW; Chen YC; Hsiao CH
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):182-7. PubMed ID: 16808679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical apraclonidine to diagnose Bernard-Horner syndrome.
    Kocabora M; Gocmez E; Taskapili M
    Bull Soc Belge Ophtalmol; 2009; (312):9-15. PubMed ID: 19927485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.
    Watts P; Satterfield D; Lim MK
    J AAPOS; 2007 Jun; 11(3):282-3. PubMed ID: 17572343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital Horner's syndrome and the usefulness of the apraclonidine test in its diagnosis.
    Mirzai H; Baser EF
    Indian J Ophthalmol; 2006 Sep; 54(3):197-9. PubMed ID: 16921219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical apraclonidine in the diagnosis of suspected Horner syndrome.
    Freedman KA; Brown SM
    J Neuroophthalmol; 2005 Jun; 25(2):83-5. PubMed ID: 15937427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-negative apraclonidine testing in acute Horner syndrome.
    Dewan MA; Harrison AR; Lee MS
    Can J Ophthalmol; 2009 Feb; 44(1):109-10. PubMed ID: 19169332
    [No Abstract]   [Full Text] [Related]  

  • 13. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM
    Arch Ophthalmol; 2005 Apr; 123(4):578; author reply 578. PubMed ID: 15824244
    [No Abstract]   [Full Text] [Related]  

  • 14. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.
    Koc F; Kavuncu S; Kansu T; Acaroglu G; Firat E
    Br J Ophthalmol; 2005 Nov; 89(11):1442-4. PubMed ID: 16234449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apraclonidine for the pharmacologic confirmation of acute Horner syndrome.
    Nguyen MTB; Farahvash A; Zhang A; Micieli JA
    J Neurol Sci; 2020 Dec; 419():117190. PubMed ID: 33075593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM; Aouchiche R; Freedman KA
    Arch Ophthalmol; 2003 Aug; 121(8):1201-3. PubMed ID: 12912704
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible effect of systemic sympathicolytic drugs on apraclonidine test.
    Martín-Moro JG; Botín DM; Muñoz-Negrete FJ
    Can J Ophthalmol; 2009 Aug; 44(4):463; author reply 463-4. PubMed ID: 19606173
    [No Abstract]   [Full Text] [Related]  

  • 18. Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke.
    Lebas M; Seror J; Debroucker T
    J Neuroophthalmol; 2010 Mar; 30(1):12-7. PubMed ID: 20182200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. But it's not all there.
    Peterson JD; Bilyk JR; Sergott RC
    Surv Ophthalmol; 2013; 58(5):492-9. PubMed ID: 22784676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome?
    Kardon R
    J Neuroophthalmol; 2005 Jun; 25(2):69-70. PubMed ID: 15937425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.